
SMi are pleased to announce their second annual ADC summit 2013. This event has a world leading speaking faculty that will provide the latest insights on antibody-drug conjugates.
Antibody drug conjugates are at the forefront of targeted chemotherapy for the treatment of cancer. Anticipated use of ADCs over the next 5-10 years in set to increase by 40-50% specifically within cancer research. This huge surge in programme is down to highly succesful clinical trials and results that indicate a leap forward in targeted therapeutic delivery, with monoclonal antibodies being used as a springboard for this huge success.
A unique event held in London, let ADC 2013 show you how and where the latest technologies and clinical data have transformed this field. Hear from recent advances in conjugate chemistry, target selection, novel payload deliveries, future ADC pipelines and regulatory issues.
The event will be presented via case studies by those who are working within the latest patents on new molecules. See the latest clinical data on ADCs pushing through trials in I-IV and methods to select antibody platforms that will be most effective against specific diseases.
Drug Discovery
Biologics
Biologics generation
Antibody research
Antibody conjugate development
Antibody conjugate discovery
Biomelecular Research
Genomics Research
Antibody Engineering
Protein Sciences
Protein Technologies
Bioanalyticcs
Cell Assays
Molecular Cell Biology
Pharamacology Regulatory Affairs
CMC
Alaska TSA Aviation Operations; AMRDEC; ANNISTON ARMY DEPOT; arsenal research; BAE SYSTEMS,; Battelle; Boeing-Tactical Aircraft St. Louis; College of Southern Nevada; Discover Wisconsin; ECC; GlaxoSmithKline; Hermann Pipersberg Jun G Mb H; Hexing Electrical Co Ltd; HTG Technologies; Hutchison 3g; I B M; I C S A (India) Ltd; Lansdale Semiconductor; M I T; Medway Council; Ministry Of Defence - Directorate General Of Armaments; Public Works And Government Services Canada; Qalhat Lng; South Hook Gas Company Ltd; Sprout Consulting; The Goyak Group; The Tolliver Group; Troy 7; University of Strathclyde; Us Air Forcee Academy; Vectors Inc;